Many patients with rheumatic diseases refrain from telling their doctors about all physical and emotional symptoms they’re ...

Rheumatoid arthritis (RA) patients who achieved sustained remission had better long-term outcomes than those with lingering ...

Substantial improvements in ultrasound technology and expanded use of it have necessitated an update of the 2012 ...

AbbVie (ABBV) took a big hit after an adult schizophrenia drug missed its primary endpoint in mid-stage trials. Analysts are ...

Nurix Therapeutics, Inc. (Nasdaq: NRIX), a clinical stage biopharmaceutical company developing targeted protein modulation drugs designed to treat patients with cancer and inflammatory diseases, today ...

WASHINGTON, Nov. 16, 2024 /PRNewswire/ -- Physicians are learning how to better support the needs of people with rheumatoid arthritis (RA) from online search trends, according to a new study from ...

against rheumatoid arthritis and atopic dermatitis. AbbVie’s immunology treatments generate approximately 50% of total revenue, oncology products contribute about 30%, neuroscience adds roughly 10%, ...

Use of an implantable vagus nerve stimulation device was safe and effective for treating RA among patients who previously failed treatment with at least 1 b/tsDMARD.

Researchers found that while some patients showed gut instability, others with stable microbiomes did not progress to ...

Sixty-nine-year-old Mary Anne Laporte was diagnosed with knee arthritis 15 years ago. For years, she kept the pain under control with steroid injections and physical therapy, but when she began ...

The use of biologic and targeted therapies for children with juvenile idiopathic arthritis (JIA) surpassed more typical ...